Actonel for osteoporosis cleared for use once per month
A new dosage form of once per month is now available for the osteoporosis drug Actonel.
Actonel (risedronate sodium), which is now available in daily, weekly, and two-tablets-per-month dosage forms, has now been approved for once a month (150 mg) administration. Co-promoted by Procter & Gamble and sanofi-aventis, the
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
